Abstract
One of the greatest challenges of the post-genomic and post-proteomic era is to understand the role of posttranslational modifications in global biological systems. Protein glycosylation is one of the most frequent posttranslational modifications but has been poorly studied in global proteomes because of analytical challenges associated with glycan structural characterization. In recent years, technical advances in the study of protein glycosylation have been achieved by the use of lectins as an enrichment tool for subproteomes modified by specific types of glycan structures. Many clinical biomarkers are glycoproteins and glycoproteomic studies that use lectin affinity techniques have been shown to have a superior ability to determine structure-specific biomarkers of disease. This article reviews key techniques and workflows, including the use of single- and multiple lectin columns and glycan detection by lectins.
Keywords: Affinity purification, cancer, glycoproteomics, human disease, lectins, mass spectrometry, microarrays, protein separation, post-genomic, post-proteomic, glycoproteins, clinical biomarkers
Current Proteomics
Title: Lectin Techniques for Glycoproteomics
Volume: 8 Issue: 4
Author(s): Carol L. Nilsson
Affiliation:
Keywords: Affinity purification, cancer, glycoproteomics, human disease, lectins, mass spectrometry, microarrays, protein separation, post-genomic, post-proteomic, glycoproteins, clinical biomarkers
Abstract: One of the greatest challenges of the post-genomic and post-proteomic era is to understand the role of posttranslational modifications in global biological systems. Protein glycosylation is one of the most frequent posttranslational modifications but has been poorly studied in global proteomes because of analytical challenges associated with glycan structural characterization. In recent years, technical advances in the study of protein glycosylation have been achieved by the use of lectins as an enrichment tool for subproteomes modified by specific types of glycan structures. Many clinical biomarkers are glycoproteins and glycoproteomic studies that use lectin affinity techniques have been shown to have a superior ability to determine structure-specific biomarkers of disease. This article reviews key techniques and workflows, including the use of single- and multiple lectin columns and glycan detection by lectins.
Export Options
About this article
Cite this article as:
L. Nilsson Carol, Lectin Techniques for Glycoproteomics, Current Proteomics 2011; 8 (4) . https://dx.doi.org/10.2174/157016411798220808
DOI https://dx.doi.org/10.2174/157016411798220808 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Current Molecular Pharmacology PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence
Current Drug Targets Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology Telomerase Inhibitors as Anticancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents P53 Family: At the Crossroads in Cancer Therapy
Current Medicinal Chemistry Taxotere Chemosensitivity Evaluation in Rat Breast Tumor by Multimodal Imaging: Quantitative Measurement by Fusion of MRI, PET Imaging with MALDI and Histology
Recent Patents on Medical Imaging Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Current Gene Therapy MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53
Current Medicinal Chemistry Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals HGF-Antagonists: Structure, Activities, and Anti-cancer Approach
Current Signal Transduction Therapy Zebrafish: Predictive Model for Targeted Cancer Therapeutics from Nature
Current Cancer Drug Targets Nanomedicine based on Nucleic Acids: Pharmacokinetic and Pharmacodynamic Perspectives
Current Pharmaceutical Biotechnology Oxidative Stress and Mitochondrial Dysfunction in Type 2 Diabetes
Current Pharmaceutical Design Regulation of Mitochondrial Function and its Impact in Metabolic Stress
Current Medicinal Chemistry <i>Click</i> Reaction in the Synthesis of Dendrimer Drug-delivery Systems
Current Medicinal Chemistry Pharmacodynamics of Memantine: An Update
Current Neuropharmacology T Cell Suicide Gene Therapy to Aid Haematopoietic Stem Cell Transplantation
Current Gene Therapy Prostaglandin J2 Family and the Cardiovascular System
Current Vascular Pharmacology Pretargeted Radioimmunotherapy with α-Particle Emitting Radionuclides
Current Radiopharmaceuticals Hydrolyzed Rutin Decreases Worsening of Anaplasia in Glioblastoma Relapse
CNS & Neurological Disorders - Drug Targets